— Know what they know.
Not Investment Advice

BGMD OTC

BG Medicine, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -0.0% 5Y: -99.5%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 54 · $1137 mcap · 8M float · 0.0082% daily turnover

Balance Sheet Trends

Total Assets
$2M -59.2% ▼
5Y CAGR: -21.2%
Total Liabilities
$4M -12.1% ▼
5Y CAGR: -45.4%
Shareholders Equity
-$2M -454.8% ▼
Cash & Investments
$2M -63.0% ▼
5Y CAGR: -8.9%
Total Debt
$0 -100.0% ▼
Net Debt
-$2M -31.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2011FY2012FY2013FY2014FY2015
— Assets —
Cash$24M$13M$8M$4M$2M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$24M$13M$8M$4M$2M
Net Receivables$115K$395K$319K$174K$181K
Inventory$212K$447K$459K$400K$145K
Other Current Assets$565K$390K$0$0$0
Total Current Assets$25M$15M$9M$5M$2M
Property, Plant & Equip.$301K$197K$192K$117K$11K
Goodwill & Intangibles$456K$372K$192K$135K$77K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$37K$96K$134K$126K$94K
Total Non-Current Assets$794K$665K$518K$378K$182K
Total Assets$26M$15M$9M$5M$2M
— Liabilities —
Accounts Payable$487K$1M$965K$695K$558K
Short-Term Debt$0$3M$4M$3M$0
Deferred Revenue$1M$411K$2M$906K$250K
Other Current Liabilities$862K$776K$2M$775K$314K
Total Current Liabilities$5M$8M$7M$5M$1M
Long-Term Debt$0$7M$3M$0$0
Other Non-Current Liab.$15K$5K$111K$93K$3M
Total Non-Current Liabilities$15K$7M$3M$93K$3M
Total Liabilities$5M$15M$10M$5M$4M
— Equity —
Common Stock$20K$21K$28K$34K$11K
Retained Earnings-$113M-$137M-$153M-$161M-$166M
Accumulated OCI$0$0-$0$0-$3M
Total Stockholders Equity$21M$309K-$1M$557K-$2M
Total Liabilities & Equity$26M$15M$9M$5M$2M
— Key Metrics —
Total Debt$0$10M$7M$3M$0
Net Debt-$24M-$3M-$437K-$1M-$2M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms